SCHEDULE: Qiming Venture Partners Discloses 5.17% VOR Biopharma Stake

Qiming Venture Partners entities disclose an updated passive ownership stake in VOR Biopharma Inc., holding a combined beneficial interest of approximately 5.17%.

Summary

• Qiming Venture Partners VIII-HC, L.P. beneficially owns 1,089,767 shares, representing 2.8% of VOR Biopharma Inc.'s Common Stock.
• Qiming Venture Partners VIII Investments, LLC beneficially owns 910,172 shares, representing 2.4% of VOR Biopharma Inc.'s Common Stock.
• Qiming GP VIII-HC, LLC, as the general partner of Qiming Venture Partners VIII-HC, L.P., also beneficially owns 1,089,767 shares (2.8%).
• Qiming GP VIII, LLC, as the general partner of entities within Qiming Venture Partners VIII Investments, LLC, also beneficially owns 910,172 shares (2.4%).
• Collectively, the Reporting Persons (Qiming Venture Partners entities) beneficially own an aggregate of 1,999,939 shares, representing approximately 5.17% of VOR Biopharma Inc.'s Common Stock.
• The percentages are calculated based on 38,720,196 shares of Common Stock outstanding as of December 31, 2025.
• The reporting persons certify that the securities were not acquired for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of passive institutional ownership and does not contain new operational or financial information about the issuer.

Positives

• The disclosure of a collective 5.17% passive institutional stake by Qiming Venture Partners, a notable venture capital firm, signals continued investor confidence in VOR Biopharma Inc.

Future Outlook

No forward-looking statements or guidance provided in this filing.

Industry Context

StockSavvy.ai notes that institutional investment by venture capital firms like Qiming Venture Partners in biopharma companies such as VOR Biopharma Inc. is common, reflecting ongoing interest in the sector's growth potential and innovative therapies. This type of passive stake indicates a long-term investment perspective rather than an activist intent.

Stakeholder Impact

• This filing provides transparency to shareholders regarding the significant institutional ownership by Qiming Venture Partners, indicating a notable, albeit passive, investment in VOR Biopharma Inc.

Key Dates

Recommendation

This Schedule 13G/A filing discloses that Qiming Venture Partners and its related entities collectively hold a passive stake of approximately 5.17% in VOR Biopharma Inc. While the filing explicitly states no intent to influence control and does not provide new operational or financial performance data, the disclosure of a significant institutional stake exceeding 5% can be a positive signal of investor confidence. However, without additional information on the company's fundamentals or strategic direction, this filing alone does not provide a strong catalyst for a 'buy' or 'sell' recommendation. Therefore, a 'hold' recommendation is appropriate, advising investors to maintain their current position while awaiting further company-specific news or financial updates.

Keywords

VOR Biopharma, Qiming Venture Partners, Schedule 13G, Institutional Ownership, Biopharma, Common Stock, SEC Filing, Passive Investment